Meridiem Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$54.1M |
| 2 |
Intuit
INTU
|
+$42.3M |
| 3 |
Align Technology
ALGN
|
+$22M |
| 4 |
Mastercard
MA
|
+$18.5M |
| 5 |
Accenture
ACN
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$27.7M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$9.52M |
| 3 |
Tractor Supply
TSCO
|
+$8.35M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.1M |
| 5 |
Apple
AAPL
|
+$336K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.52% |
| 2 | Healthcare | 25.58% |
| 3 | Consumer Discretionary | 14.93% |
| 4 | Financials | 11.81% |
| 5 | Communication Services | 4.08% |
Similar funds
Meridiem Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Meridiem Investment Management held 66 positions worth $5.32B, up 4.5% from $5.1B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Meridiem Investment Management deployed $218M of net new capital in Q2 2024, opening 1 new position and adding to 19 existing holdings. Its largest new stake was Blackrock: 885 shares worth $697K.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $27.7M trimmed.
- Meridiem Investment Management's largest Q2 2024 buy was Blackrock: 885 shares worth $697K.
- Meridiem Investment Management added most to UnitedHealth in Q2 2024, an estimated $54.1M increase.
- Meridiem Investment Management's biggest Q2 2024 reduction was Amphenol, cutting an estimated $27.7M.
- Meridiem Investment Management fully exited Colgate-Palmolive in Q2 2024, selling an estimated $270K.
- Meridiem Investment Management's ten largest holdings make up 60% of its $5.32B portfolio in Q2 2024.
- Meridiem Investment Management opened 1 new position and closed 6 in Q2 2024.
- Meridiem Investment Management's portfolio value rose 4.5% quarter-over-quarter to $5.32B.
Based on Meridiem Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.